Stroke induces diverse permanent neuromuscular sequalae including hemiplegia.
Early thrombolytic intervention is the only proven therapeutic option for stroke, which is hard to be applied to most stroke patients.
ahNSCs are derived from adult human brain and make therapeutic effects for stroke by differentiation into neural cells and secretion of neuroprotective, anti-gliosis, pro-angiogenic, and anti-inflammatory paracrine factors. Project code of ahNSCs for Stroke is MS2101.
from Adult Human Temporal Lobe
Primary Culture of Brain Clumps
Adult Human Neural Stem Cells (ahNSCs)